Navigation Links
Acne Drug linked to suicide attempts

One year ago the FDA issued a statement about the potential for depression and suicide in teens taking the acne drug, Accutane. And now, reports say that the 15-year-old pilot who crashed his plane into a skyscraper was prescribed the drug. At this point, investigators don't know whether or not the teen, Charles J. Bishop, was actually taking Accutane at the time of his death. Blood tests should reveal if the drug was in his blood. //

Accutane is very effective against severe acne, but has been wrought with controversy due to some devastating adverse effects. Doctors have known for years about the potential for birth defects in women who become pregnant while taking the drug. And near the end of 2001, more concern was raised about the potential for depression and even suicide.

In October 2000, the FDA said the drug had been associated with 44 suicides since 1983. The FDA also had reports of 110 US Accutane users hospitalized for depression and thoughts of suicide in the same period. Roche, the makers of Accutane, sent a letter to doctors three-and-a-half years ago, alerting them to a new prescribing warning that states - "Accutane may cause depression, psychosis, and rarely, suicide attempts."

While the relationship between Accutane and depression remains unproven, the FDA strengthened the label warning in 1998 to say Accutane may cause depression and psychosis, and in rare cases may cause thoughts of suicide, suicide attempts and suicide.
'"/>




Page: 1

Related medicine news :

1. El Ni?o cycles linked to cholera outbreaks
2. Cancers of Colon & Rectum linked to Cigarette Smoking
3. Gene linked to early puberty in girls
4. Maternal alcohol consumption linked to behavioral problems in children
5. Gene HPA-2 Met linked to cardiac arrest
6. Early puberty linked to nutrition
7. Alcohol linked to brain activity
8. Cement injections linked to osteoporosis
9. Asthma linked to obesity
10. Miscarriage linked to late embryos
11. Cirrhosis linked to genes
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/7/2016)... ... December 07, 2016 , ... ... medicine device WellnessPro Plus for consumers and healthcare professionals to manage chronic ... by expanding the treatment modalities available in a single device. The announcement ...
(Date:12/7/2016)... ... ... “Tomorrow Trump Goes To Washington”: a brief but engaging illustration depicting ... America. “Tomorrow Trump Goes To Washington” is the creation of published author, Nancy Engestrom, ... , Nancy attributes her patriotic nature to her WWII veteran father. She says, ...
(Date:12/7/2016)... ... (PRWEB) December 07, 2016 , ... Angioma Alliance ( http://www.angioma.org ... angiomas, was awarded a grant from the Julian Grace Foundation to increase its ... more people with cavernous angioma than anywhere in the world. Most share a ...
(Date:12/7/2016)... Mateo, CA (PRWEB) , ... December 07, 2016 , ... ... San Francisco Peninsula region, is proud to announce new city-specific pages as part of ... services for the elderly, they often look, first, for local agencies serving their city. ...
(Date:12/6/2016)... ... December 06, 2016 , ... ... collaborate in developing a vaccine against the Middle East Respiratory Syndrome Coronavirus (MERS-CoV). ... available in South Korea for emergency deployment in the event of a future ...
Breaking Medicine News(10 mins):
(Date:12/7/2016)... Dec. 7, 2016  Ionis Pharmaceuticals, Inc. (NASDAQ: IONS ... present a company overview at the BMO Capital Markets Prescriptions for ... York, NY . A live webcast of the ... the Ionis website.  The replay will be available within 48 hours ... ...
(Date:12/7/2016)... 7, 2016  Lannett Company, Inc. (NYSE: LCI ) ... Markets 2016 Prescription for Success Healthcare Conference on December 14, 2016 ... New York City . In addition, the ... Guggenheim Securities 4 th Annual Boston Healthcare Conference taking place ... ...
(Date:12/6/2016)...  Alopexx Oncology, LLC announced data from a Phase ... (immunocytokine) composed of interleukin-2 and a CD20-targeting monoclonal antibody. ... cells as Rituxan and maintains the activities of both ... in tumor targeting, engagement of the immune system, and ... the study (abstract #95954) were presented at the 58 ...
Breaking Medicine Technology: